同方股份有限公司关于签署《委托管理协议之终止协议》暨关联交易进展的公告详细解读

一、事件概述

同方股份有限公司（证券代码：600100）于近期发布公告，宣布与关联方中国宝原投资有限公司（以下简称“中国宝原”）签署了《委托管理协议之终止协议》，正式终止此前签订的关于“中核医疗产业管理有限公司”部分股东权利及经营管理权的委托事项。

二、协议的历史背景及签署情况

2024年7月26日，同方股份与其原控股股东中国宝原签署了《关于中核医疗产业管理有限公司委托管理协议》，约定中国宝原将其全资子公司中核医疗产业管理有限公司（以下简称“中核医疗”）部分股东权利及经营管理权委托同方股份行使，托管期限为三年，年度委托管理费用为人民币40万元（含税）。该事项在2024年7月27日进行了对外披露，属于关联交易事项。

三、终止协议主要内容及原因

近期，因客观情况发生变化，同方股份与中国宝原签署了《关于中核医疗产业管理有限公司委托管理协议之终止协议》，双方同意自终止协议生效之日起，终止原于2024年7月26日签署的《委托管理协议》。同时，双方约定按照实际管理期限支付委托管理费用。

四、对公司的影响分析

• 经营影响：公告明确指出，终止该协议不会对公司的正常经营活动产生不利影响，也不会对公司的未来财务状况和经营成果造成重大不利影响。
• 股东利益：本次协议终止不存在损害公司及股东（尤其是中小股东）利益的情形。
• 价格敏感性分析：考虑到该事项不会对公司主营业务、财务状况或经营成果产生重大不利影响，预期对公司股价的影响有限。公告内容没有披露涉及重大资产、业绩变动或潜在并购事项，属于日常管理层面的调整，投资者可视为公司管理灵活应对变化的表现。

五、投资者关注要点

• 本次协议终止不影响公司现有的业务布局和战略发展。
• 委托管理费用将在实际管理期限内按比例支付，不会导致公司产生额外负担。
• 终止协议为公司与关联方的正常协商结果，对于公司治理结构及经营稳健性具有积极意义。

六、结论

本次公告反映出同方股份在公司治理及与关联方合作中保持灵活调整的能力。事件本身不构成重大利好或利空，预计不会对公司股票价格造成显著波动。建议投资者关注公司后续披露，保持理性判断。

免责声明：本文内容仅供投资者参考，不构成任何投资建议。股市有风险，投资需谨慎。

English Version

Detailed Analysis: Tsinghua Tongfang Announces Termination of Entrusted Management Agreement and Related Party Transactions

1. Event Overview

Tsinghua Tongfang Co., Ltd. (Stock code: 600100) recently announced the signing of a “Termination Agreement” with its related party, China Baoyuan Investment Co., Ltd. (“China Baoyuan”), effectively ending the previously agreed entrusting of partial shareholder rights and management authority over “CNNC Medical Industry Management Co., Ltd.” (hereafter “CNNC Medical”).

2. Background and Agreement Details

On July 26, 2024, Tsinghua Tongfang and its former controlling shareholder China Baoyuan entered into an “Entrusted Management Agreement” regarding CNNC Medical, in which China Baoyuan entrusted partial shareholder rights and management authority of its wholly-owned subsidiary CNNC Medical to Tsinghua Tongfang for three years, with an annual management fee of RMB 400,000 (tax included). This related party transaction was publicly disclosed on July 27, 2024.

3. Main Content and Reason for Termination

Recently, due to changes in objective circumstances, Tsinghua Tongfang and China Baoyuan signed a “Termination Agreement,” agreeing to terminate the original entrusted management agreement effective immediately. The parties will settle the management fee according to the actual management period.

4. Impact Analysis

• Business Impact: The announcement clearly states that the termination of the agreement will not adversely affect the company’s normal operations or financial results.
• Shareholder Interests: The termination does not harm the interests of the company or its shareholders, especially minority shareholders.
• Price Sensitivity: Since the event does not impact the company’s core business, financial status, or future results, any effect on the share price is expected to be limited. There is no major asset, performance, or M&A development disclosed; this is a management adjustment, signaling flexible governance.

5. Key Points for Investors

• The termination does not impact current business layout or strategic direction.
• Entrusted management fees will be settled proportionally, with no additional financial burden.
• This outcome reflects normal negotiations with related parties and is a sign of sound governance and flexibility.

6. Conclusion

This disclosure shows Tsinghua Tongfang’s ability to adapt in related party dealings and corporate governance. There is no significant positive or negative impact expected, and share price volatility is likely to be minimal. Investors are advised to monitor further disclosures and exercise rational judgment.

Disclaimer: The content herein is for informational reference only and does not constitute investment advice. Stock investment carries risk; proceed with caution.

View 同方股份 Historical chart here